Cu/Zn superoxide dismutase-1 (SOD1) mutations are causative for a subset of amyotrophic lateral sclerosis (ALS) cases. These mutations lead to structural instability, aggregation and ultimately motor neuron death. We have determined crystal structures of SOD1 in complex with a naphthalene-catechol-linked compound which binds with low micro-molar affinity to a site important for oxidative damage-induced aggregation. SOD1 Trp32 oxidation is indeed significantly inhibited by ligand binding. Our work shows how compound linking can be applied successfully to ligand interactions on the SOD1 surface to generate relatively good binding strength. The ligand, positioned in a region important for SOD1 fibrillation, offers the possibility that it, or a similar compound, could prevent the abnormal self-association that drives SOD1 toxicity in ALS.
Human superoxide dismutase 1 (SOD1) protects cells against reactive oxygen species by dismuting the superoxide anion radical to H 2 O 2 [1] . SOD1 was the first gene linked to the neurodegenerative disease amyotrophic lateral sclerosis (ALS) [2] . ALS is a fatal neurodegenerative disease characterized by degeneration of motor neurons leading to paralysis and ultimately death. To date, more than 160 mutations have been identified which are associated with familial ALS (fALS) [3] . These mutations account for roughly 20% fALS cases [4] . ALS-related SOD1 mutations are scattered throughout the five exons of the SOD1 gene and the resulting polypeptide [5] . SOD1-ALS results from an inability of the nascent protein to complete the necessary steps to reach a stable and active state [6] [7] [8] [9] . Immature SOD1, lacking copper, zinc and its intrasubunit disulfide bond can inhabit a globally or partially unfolded state in which only b-strands 1, 2, 3 and 6 remain intact [10] [11] [12] . This ultimately leads to aggregation through abnormal protein-protein contacts and disturbance of cellular homeostasis [11, 13, 14] . The general strategy to inhibit SOD1 pathogenic aggregation is by stabilization of the SOD1 native dimer [15] . This may include promoting folding, decreasing dimer dissociation or occlusion of the interfaces which mediate aggregate initiation or elongation.
The SOD1 monomer is likely a precursor of the lower order soluble oligomers that harbour toxicity and initiate the aggregation cascade [16, 17] observed in SOD1-ALS cases [18, 19] . Crystal structures of both A4V and I113T [20] and molecular dynamics simulations [16, 21] support the hypothesis that toxicity of fALS-SOD1 variants involves dimer destabilization. Conversely, stabilization of the SOD1 dimer has been shown to increase the protein's thermostability, prevent monomerization and inhibit aggregation [17, 22] . Cross-linking or platination at the dimer interface Cys111, for example, has so far proved the most effective method to tackle the Abbreviations b-ME, b-mercaptoethanol; ALS, amyotrophic lateral sclerosis; fALS, familial ALS; RU, response unit; SOD1, superoxide dismutase 1; SPR, surface plasmon resonance.
biophysical characteristics of mutant SOD1 that cause ALS [22, 23] ; however, targeting free sulphydryls is complicated by off target binding.
SOD1 has an unusually solvent-exposed tryptophan residue on the b-barrel surface. The Trp32 side chain ring system can be broken by oxidation in vivo and this potentiates aggregation and cytotoxicity [24] [25] [26] [27] [28] [29] . SOD1 aggregates appear to be an irregular repetition of partially folded SOD1 monomers scaffolded loosely by the structured b-strands found in the immature state [30] [31] [32] . Substitutions within b-strand 3, including Trp32 but also at Gly33, inhibit SOD1 aggregation in motor neurons [27, 32] . Similarly mouse SOD1, which has serine in place of Trp32, is not accumulated into human mutant SOD1 aggregates when they are expressed in transgenic animals. The SOD1 b-strand 2-3 region is, therefore, a good target for disruptive inhibition of aggregation by an exogenous drug compound.
Two sites amenable to ligand interactions in the bstrand 2-3 region have previously been described [33, 34] . By following a fragment-based drug discovery approach, a series of linked compounds were derived from these hits which aimed to incorporate binding to both Trp32 and loop II sites [35] . In our present work, we have considered one of these compounds (1-(3,4-dihydroxyphenyl)-2-((naphthalen-1-ylmethyl)amino) ethan-1-one; SOD1-binding ligand-1, SBL-1 hereafter) and successfully solved the crystal structure of SOD1 in complex with SBL-1. Also, we have determined the crystal structure of SOD1 in complex with isoproterenol in the C222 1 space group, different space group (P2 1 ) which was reported by our group [33] . Biochemical studies by surface plasmon resonance (SPR) assay confirm that these SBL-1 and isoproterenol bind to SOD1 with low micro-molar affinity.
Material and methods

Chemical and reagents
All the reagents and chemicals were commercially available, expect SBL-1, and were used without further purification. The reagents for crystallization screening were purchased from Hampton Research, USA, and Sigma, Bangalore, India.
Protein production
The human SOD1 (hSOD1) gene containing an insertion encoding for a hexa-histidine tag in the N-terminal region was cloned into a pETM11 expression vector and was expressed in BL21Star (DE3) (Stratagene, Agilent Technologies India Pvt. Ltd., Bangalore, India) bacterial host. SOD1 mutants were planned based on SBL-1 interacting residues (Trp32 and Glu21) of SOD1 and prepared in pETM11 using Q5 Ò SiteDirected Mutagenesis Kit from NEB (New England Biolabs Inc., Ipswich, MA, USA). SOD1 and its mutants were expressed with 0.5 mM IPTG as a soluble protein at 20°C for overnight. After harvesting, cells were lysed with 50 mM NaH 2 PO 4 , pH 8.0, 300 mM NaCl, 5 mM b-mercaptoethanol (b-ME), 1 mM PMSF and 10 mM imidazole, and sonicated in batches (Vibra cell) at 30% amplitude with 3 s pulse on and 5 s pulse off. The homogenate was clarified by ultracentrifugation at 2000 r.p.m. for 1 h at 4°C. The supernatant was loaded onto a Ni-NTA column (HiTrap HP; GE Healthcare, Little Chalfont, UK) equilibrated with the lysis buffer. Protein was eluted with a 100 and 200 mM imidazole gradient in the above lysis buffer. Fractions containing pure SOD1 were pooled, and desalted against 20 mM Tris pH 8.0, using Hiprep 23/10 desalting column (GE Healthcare). To remove the tag, the tobacco etch virus protease was used and incubated at 4°C on a rocker for overnight. The protein was then concentrated to 5 mL and then loaded on to a SEC column (Superdex 75G 16/60 from GE Healthcare was used) using € AKTA Prime plus (GE Healthcare, USA). The pure SOD1 protein was finally concentrated to 10 mgÁmL À1 and aliquoted, flashfrozen in liquid nitrogen and stored at À80°C.
Crystallization of hSOD1
Since initial experiments using established crystallization buffers from the literature were not successful in giving bigger crystals, a search for new crystallization conditions was carried out at 20°C using the hanging-drop vapour-diffusion method with Hampton Research Screen I and II crystallization reagents. For screening, the protein concentration was adjusted to 8-9 mgÁmL À1 in 20 mM Tris pH 8.0. Drops consisting of 1 lL protein mixed with 1 lL reservoir solution were prepared in 24-well plates and were equilibrated against a 500 lL reservoir solution. Conditions that produced crystals were optimized with the hanging-drop and sitting drop method, varying the precipitant concentration and pH to increase the size of the crystals and to reduce the amount of nucleation. Diffraction quality crystals were obtained, within a day, in condition with a major precipitant, sodium citrate, pH 6.0. This crystallization condition differed from those that had been published previously. Crystals were grown with two different morphologies within the same drop; moreover, it possesses two different space groups (discussed below).
Ligand soaking and X-ray crystallography
Crystals grown in the P6 3 22 and C222 1 space groups were soaked with compounds (50 mM stock) dissolved in 1.5 M Sodium Citrate pH 6.0 for 3 h, 6 h and overnight at 20°C. X-ray crystallographic data sets were collected on the beamline BL-14 at ESRF, Grenoble, France. The diffraction data was also collected for the native SOD1 crystal. Diffraction data were integrated and scaled using HKL2000 [36] or IMOSFLM [37] . The crystal structures were solved by the molecular replacement method using the program, MOLREP [38] incorporated into the CCP4 software package (Collaborative Computational Project, Number 4, 1994). The SOD1 dimer structure (PDB Id: 4A7S [33] ) was used as a model for structure determination. The structure solution yielded five dimers of SOD1 in the asymmetric unit, for all the three crystals. The 2|Fo| À |Fc| maps unambiguously revealed the electron density corresponding the SOD1 protein, in all the crystal structures. Moreover, the difference Fourier, |Fo| À | Fc| maps also revealed corresponding to the molecules SBL-1 and isoproterenol, in the SBL-1 and isoproterenol complexes, respectively. The energy minimized coordinates and crystal information files for SBL-1 and isoproterenol were produced using JLIGAND [39] . The initial refinement of the structures was performed using the module PHENIX.REFINE of the PHENIX package [40] . In the later stage of the refinement cycles, the refinement of the SOD1, SBL-1 complex and isoproterenol complex were performed using REFMAC5 [41] , incorporated in the CCP4 package. Cycles of refinement and model building were done using REFMAC [41] and COOT [42] [43] . The X-ray data collection, scaling and refinement statistics are summarized in Table 1 . The structural coordinates of the native SOD1, SBL-1 and isoproterenol complexes have been deposited in the RCSB (PDB Ids: 5YUL, native SOD1; 5YTO, SBL-1 complex; 5YTU, isoproterenol complex). 
Surface plasmon resonance
To check the binding affinity of the protein molecules with hSOD1, the SPR assay was carried out. We performed SPR experiments with a Biacore T100 and Biacore 3000 (GE Healthcare) instruments. The immobilization involves activation of carboxymethyl groups on a dextran-coated chip by reaction with N-hydroxysuccinimide, followed by covalent bonding of the proteins to the chip surface via amide linkages and blockage of excess activated carboxyls with ethanolamine. Reference surfaces were prepared in the same manner, except that all carboxyls were blocked and no protein was added. Reference was used to normalize the response unit (RU) values of protein. PBS with 5% DMSO was used as both running and analyte-binding buffer. Ligand molecule (analyte) was allowed to flow over the immobilized-protein surface and the binding response of analyte to protein was recorded. The chip surface was regenerated by the removal of an analyte with a regeneration buffer. The maximum RU with each analyte indicates the level of interaction and reflects comparative binding affinity. Binding curves were displayed, and the dissociation constants (K D ) for the interaction were determined using the steady-state affinity method incorporated in the BIAEVALUATION 4.1 software (GE Healthcare).
Tryptophan oxidation assay
The tryptophan oxidation assay was performed as per the recently reported protocol [44] . Fluorescence spectroscopy was used to study the kinetic profile of Trp residue consumption induced by AAPH derived. A reaction mixture containing protein (5 lM) with 6 mM AAPH (2,20-azobis(2-amidinopropane) dihydrochloride) was incubated in 100 mM phosphate buffer, pH 7.4 at 45°C. Trp consumption was evaluated from the progressive decrease of the fluorescence intensity at 360 nm (excitement wavelength 295 nm). The fluorescence intensity was measured for 90 min with 2 min of time intervals. W32A SOD1 mutant was used as a control as there will not be any fluorescence in the absence of Trp. The oxidation assay was carried out for the wild-type SOD1 in the presence of SBL-1 or isoproterenol compounds, and for the E21A mutant in the presence of SBL-1. For all reactions, 50 lM compounds were used. All the experiments were done in triplicate and standard deviations were calculated for each assay. The experiment was performed using an Aminco-Bowmen Series 2 Luminescence spectrometer (Thermo Electron Corporation, Beverley, MA, USA).
Results and Discussion
The crystal structures of the hSOD1 and its complexes with the SBL-1 and isoproterenol were determined and refined to 1.9 A resolution. In all these crystal structures, the asymmetric unit contains five biologically relevant dimers (Fig. 1A,B) . The SOD1 and SBL-1 complex were crystallized in the P6 3 22 space group, and the isoproterenol complex was crystallized in the C222 1 space group. Though the structures of SOD1 and the isoproterenol complex were already known, the reported structures were crystallized in different space groups. Moreover, the binding mode of the isoproterenol compound in the present structure is also different (discussed below). The monomer of SOD1 forms an eight-stranded Greek key b-barrel topology. Two long loops (loop IV: residues 67-78; loop VII: residues 126-141) protruding from the b-barrel are responsible for metal binding and forming the walls of the active site. The 'disulfide loop' (residues 50-62) involved in forming a disulfide bond between Cys57 and Cys146 which lies on the b-barrel. In the chain J of all these three crystal structures, the electron density corresponding to the regions encompassing residues 67-78 (loop IV) and residues 126-141 (loop VII) was absent. It may be due to the absence of Zn ion in this chain. The Cu ion is missing in all these crystal structures. However, overall tertiary structures are very similar to each other, and the known typical SOD1 homodimer (not shown). The crystallographic and refinement data are summarized in Table 1 .
Structure of the SOD1-SBL-1 complex
The synthesis of SBL-1 has been reported elsewhere [35] . Three molecules of SBL-1 are found within the crystallographic asymmetric unit. Two SBL-1 molecules (P and Q) are sandwiched in the interface produced by the chain B (AB dimer) and the chain H (of GH dimer) of hSOD1 ( Fig. 2A,B) . The naphthalene moiety of P and Q make p-p interactions with the Trp32 indole ring of B and H chains, respectively. The electron density in this region is not well-defined suggesting that the naphthalene moiety of SBL-1 may possess multiple conformations. The atom 'O3' methyl-amino linker of the molecule, P possesses a steric clash with the dihydroxy phenyl moiety of the molecule, Q. The electron density observed in this region unambiguously revealed the steric clash by the atom 'O3'. As the methyl-amino linker and the isoquinoline region are rather dynamic as observed in the crystal structure, the atom 'O3' of the molecule, Q forms a weak hydrogen bond with the side chain of Glu100 in chain H.
The dihydroxy phenyl moiety of the molecule, P, is positioned in a small shallow pocket formed by the loop II connecting the b-strands b2 and b3 (Fig. 2C) . The hydroxyl groups dihydroxy phenyl contribute significant hydrogen bond interactions with the main chain carbonyl group Pro B28. The atom 'O1' of the molecule, P, also forms hydrogen bonds with the amino group of Lys B23 and a buried water molecule. The atom 'O2' of the molecule P contributes another hydrogen bond with the side chain of Glu B100. In the molecule, Q, the dihydroxy phenyl moiety is stabilized by hydrophobic interaction with the aliphatic side chain of Glu B21. The atom 'O3' makes a weak electrostatic interaction with the side chain of Glu F100. Intriguingly, the third molecule R of SBL-1 binds in the interface produced by loops I and I 0 connecting the b-strands b1 and b2 of the chains C and D' (symmetry related molecule) of hSOD1 (Fig. 2D,E) . As this binding site is predominantly exposed to the solvent region, the electron density corresponding to the methyl-amino and isoquinoline regions are completely absent. The dihydroxy phenyl moiety of the molecule, R is sandwiched between Pro C13 and the aliphatic side chain of Lys D9 0 (Fig. 2F) . The atom 'O2' contributes two hydrogen bonds with the N2 atom of Lys D9 0 and OE1 of Gln D15 0 , while the atom 'O1' make hydrogen bonds with OE1 of Gln D15 0 and a buried water molecule. Intriguingly, the buried water molecule, in addition to the interaction with SBL-1, it contributes significant electrostatic interactions with the carbonyl groups of Gly D10 0 , Gly D12 0 and Val D14 0 and with the amino group of Gly D10 0 . Overall, the structure of the SBL-1 complex suggests that the SBL-1 molecule cannot bind the interface of the native SOD1 dimer, instead it specifically binds near the Trp32 site. In addition, though the crystal packing analysis of the SBL-1 complex (not shown) suggests the oligomeric nature of SOD1, SBL-1 is unlikely to promote the oligomerization as the crystal of the SBL-1 complex was obtained by soaking method.
Structure of the isoproterenol complex
Isoproterenol also binds in the interface formed by the loops I and I' as found in the SBL-1 complex for the molecule R (Fig. 3A) . Though the electron density corresponding to the dihydroxy phenyl moiety is clearly visible, the flexible methyl-amino group is not observed in the crystal structure as this region does not interact with the protein molecule. The side chain of Gln 15 0 makes hydrogen bonds with the two hydroxyl groups of phenyl moiety (Fig. 3B) . The hydroxyl groups also contribute electrostatic interactions with Lys 9 0 and a buried water molecule. As observed in the SBL-1 complex, the buried water molecule also makes potential hydrogen bonds with Gly10 0 , Gly12 0 and Val 14 0 . In the previous known structure of the isoproterenol complex (PDB Id: 4A7T) [33] , which was crystallized in the P2 1 space group, the compound was found in a hydrophilic pocket produced by SOD1 loop II, different from the present binding site region.
Comparisons of SBL-1 pose with those of aniline and quinazoline
The crystal structures of aniline in complex with L38V SOD1 (PDB Id: 2W20) and a quinazoline derivative with G93A SOD1 (PDB Id: 2WZ6) have previously been reported [34] . By comparing the SBL-1 complex (in the molecules P and Q binding site) with the above-mentioned crystal structures, the binding mode of the naphthalene moiety is similar to that found in the aniline and quinazoline complexes (Fig. 4A,B) . In each case, a cyclic ring system makes p-p stacking interactions with Trp32. The main structural difference in the binding site region is that the side chain of Trp32 in the SBL-1 complex is flipped to form a stacking interaction with the naphthalene moiety. The conformations of the side chains in the residues Lys3 and Glu21 are also different in the hydrophilic binding site. These conformational changes are necessary to accommodate the ligand in the Trp32 binding site as well as to avoid a steric clash between Glu21 and Trp32.
Superimposing the SBL-1 complex with isoproterenol in complex with I113T SOD1 ( [33] ; PDB Id: 4A7T; rmsd: 0. 29 A for all atoms) shows that the catechol group of SBL-1 exactly mimics the pose of the isoproterenol catechol making identical inter-molecular interactions with the protein (Fig. 4C) . Taken together, the binding mode of SBL-1 combines elements of aniline/quinazoline and isoproterenol binding modes. Though the designed molecule SBL-1 binds well to hSOD1 as expected, the linker group should be considered when designing the next series of compounds for better affinity with hSOD1.
The SPR assay
To analyse the strength of SBL-1 and isoproterenol interactions with SOD1, SPR assays were performed. pH scouting was done to the amount of immobilized SOD1 on the CM5 chip was up to 3254 RUs for the 420 s of coupling time. For SPR analysis, six different concentrations of SBL-1 and isoproterenol were used. The two ligands showed concentration-dependent binding as expected and quickly reached steady state. The binding constants (K D ) of ligands to SOD1 were obtained by employing steady-state fitting methods. From the steady-state binding analysis, the K D for the interaction of SBL-1 and isoproterenol with SOD1 was found to be 33.1 and 12.0 lM, respectively (Fig. 5) . The SPR analyses correlates well with the crystal structure of the complexes, where we can find significant ligand and protein interactions.
Tryptophan oxidation assay
We speculated SBL-1 may inhibit the oxidation of SOD1 Trp32 due to the proximity of binding. The kinetic profile of protein Trp residue consumption induced by AAPH-derived radicals was assessed by fluorescence spectroscopy [44] . Protein fluorescence with and without compounds (SBL-1 or isoproterenol) was compared with a W32A mutant control. The W32A mutant, with and without SBL-1, does not show any fluorescence change, and hence, the F/F0 (normalized data) value is near to 1.0 over time (Fig. 6) . Wild-type SOD1, in the absence of the compounds, showed the Trp consumption over time in the presence of AAPH. As shown in Fig. 6 , SBL-1 showed significant inhibition of Trp oxidation compared with isoproterenol. Intriguingly, the kinetic profile of SOD1 in the presence of SBL-1 resembles that of W32A mutant suggesting that the SBL-1 compound protects Trp32 from oxidation. This may be due to the ᴨ-ᴨ stacking interaction of naphthalene ring structure with the Trp32 residue of the SOD1, in addition to the electrostatic interaction due to dihydroxy phenyl moiety, may be responsible to inhibit the Trp oxidation. Surprisingly, the isoproterenol compound possesses a weak inhibition of Trp oxidation. It may be due to the presence of weak hydrophobic interaction between the linker region of dihydroxy phenyl moiety and Trp32 of SOD1 as well as the presence of hydrophilic interaction of Glu21, which is common both in the isoproterenol and SBL-1 complexes, through O3 atom of dihydroxyphenyl moiety (Fig. 1A) . As expected, the kinetic profile of E21A mutant in the presence of SBL-1 showed lesser inhibition when compared with the kinetic profile of wild-SOD1 (Fig. 6B ). This suggests that SBL-1 interaction with E21 residue has its effect on binding efficiency with the protein.
Near the loop VI at the dimer interface
Each SOD1 monomer contains four cysteines (Cys6, Cys56, Cys111 and Cys146) in which Cys6 and Cys111 are in free form, and a disulfide bridge is formed between Cys57 and Cys146. The free cysteine, Cys111 which lies in the loop VI, is a highly 'reactive cysteine' [25, 45] . The oxidized Cys111 form of hSOD1 leads to misfolding and aggregation, a typical characteristic of the pathophysiology of ALS [24, 25] .
Intriguingly, a stretch of electron density is observed between Cys111 residues in three dimers of the asymmetric unit. This feature is observed both in the SOD1 and the isoproterenol complex crystal structures (AB, CD, EF and IJ in hSOD1; AB, CD and EF dimers in the isoproterenol complex). The corresponding electron density is nicely fit by a polysulfane (Fig. S1 ). The polysulfane comprises six sulfurs (hexasulfane) linking Cys111 of one monomer and Cys111 of another monomer (Cys -S4 -Cys) in the dimer interface (Fig. S1A) . A similar polysulfane linkage between the Cys111 residues in the mutant H46R/H48Q SOD1 crystal structure (PDB Id: 3K91) has been reported [46] . Though the distance between the two Cys111 residues is same (~8.2 A) in our structure as well in the reported structure (PDB Id: 3K91), one sulfur atom is lacking. You et al. [46] have established using biochemical and structure studies that heptasulfane (seven sulfurs) bridge two Cys111 residues (Cys -S5 -Cys bridge) in the dimer. It has been suggested that elemental sulfur alone can form the polysulfane [47] . Organic polysulfur molecules are found in several organisms including algae, bacteria and plants [48, 49] ; hence, we assume that the polysulfur synthesized from the bacterial expression system in which hSOD1 was expressed may be the reason for observing in the hSOD1 dimer. Our studies also suggest that polysulfanylation can also occur in the wild-type SOD1.
In the SBL-1 complex structure, we observed a different feature of electron density near the Cys111 region (AB, CD and EF dimers) (Fig. S1C) . The electron density stretch is rather perpendicular to the Cys111 residues instead of connecting the Cys111 residues. The electron density is nicely fit by a pentasulfane (five sulfurs) molecule.
Moreover, another unexpected feature was also observed in the side chain of Cys111 residues of these dimers. The difference Fourier map corresponding to the Cys111 residues (in B, D, E and F chains) unambiguously revealed that b-ME molecule is covalently linked to the sulfur atom of Cys111 to form Cys-2-ME (CME, hereafter) (Fig. S1C,D) . In the EF dimer, both Cys111s were modified to CME (Fig. S1D) , whereas only one Cys111 residue in another dimer (B chain in the AB dimer and D chain in the CD dimer) was modified to CME (Fig. S1 ). The recently reported crystal structure of b-ME-modified (2-ME) SOD1 (2-ME-SOD1) was shown that both Cys111 residues in the dimer were modified to CME ( [26] , PDB Id: 3T5W), and are similar to that observed in the SBL-1 complex (not shown). The pentasulfane (five sulfurs) molecule is inserted into the site covered by the side chains of Cys111-2-ME's, loop VI of chain E and F and the Ile113 residues on the rear side of the pentasulfane molecule (Fig. S1D) .
Conclusion
The heterogeneity of mutant SOD1 characteristics has slowed progress towards a unified understanding of SOD1-ALS pathogenesis and new means with which to treat the disease. For instance, many, but not all, SOD1 mutants are thermally destabilized. Some are inactive while others have more than 100% activity in vitro [50] . Several exist as a monomer at physiological concentrations, while others dimerize almost exactly like the wild-type [51] . Mutant SOD1 aggregation is, however, the central characteristic of SOD1-related ALS [52] . Based on computational studies, it has been shown that the aggregate structure is not formed by a simple stacking of the monomer but that it is composed of the structured and unstructured components of the partially folded state of SOD1 [53] . Other studies have shown that small oligomers (trimerization) of SOD1 are toxic so sequestering the SOD1 trimer or preventing its formation may be a potential strategy for the management of ALS [54] . As such inhibiting the self-interactions which allow fibrils to initiate, or extend, has potential to be a comprehensive therapeutic strategy.
The b-strand 2 and 3 part of the SOD1 b-barrel is known to be both amylogenic and form the core of aggregate fibrils [7, 32, 55, 56] . Furthermore, this region also contains the solvent exposed and oxidation prone Trp32 which appears to have an important role in hSOD1 aggregation [27] . Several small molecules have been observed crystallographically to bind SOD1 in this region: Quinazoline analogues bind to SOD1 on this surface and interact with Trp32 [33, 34] , while the catechol group of isoproterenol, adrenaline and dopamine interleaves between strands in loop II [33] . Compounds, including SBL-1, synthesized with the aim of linking these two binding sites were found to be insoluble and proved difficult co-crystallize with SOD1 [35] . Here, we have overcome these difficulties and successfully obtained SOD1-SBL-1 co-crystals. As expected, the binding mode of SBL-1 is equivalent to a combination of quinazole and isoproterenol: hydrophobic interactions with Trp32 and hydrophilic interactions in the loop II region.
Our structures show two separate SBL-1 molecules binding at similar sites in two adjacent SOD1 molecules. This is likely to have aided ligand positioning in the site and facilitated our observations. Moreover, isoproterenol and SBL-1 both possesses a significant affinity for SOD1: 11.9 and 33 lM, respectively, as determined by SPR assay. This indicates our crystallographic structures are not artefactual. Indeed, demonstration of low micro-molar affinity for these surface binding ligands on a protein surface devoid of obvious cavities is a significant development in the search for SOD1-ALS lead compounds. SBL-1, in particular, has the potential to block Trp32 oxidation [18] [19] [20] through p-p interactions with the indole ring and occlude the b-barrel surface known to form the core of SOD1 fibrils. The Trp-oxidation assay confirmed the significant inhibition of SBL-1 on Trp32 oxidation, and the residue E21, which makes electrostatic interactions with SBL-1, is a critical residue for making a stable protein complex. Despite utilizing the loop II and Trp32 binding sites the affinity of SBL-1 for SOD1 is, however, slightly lower than isoproterenol. This represents a reduction in ligand efficiency which may be overcome by further optimization of the linker between catechol and naphthalene moieties.
